Browsing Tag
MHRA
21 posts
How UK’s new point-of-care drug manufacturing rules will transform cancer and gene therapies
The UK’s world-first point-of-care manufacturing law transforms advanced therapy delivery—discover how it changes cancer and gene therapy access.
July 23, 2025
MHRA approves Bayer’s Lynkuet as first non-hormonal treatment for menopause hot flushes
Bayer’s Lynkuet becomes the world’s first approved non-hormonal menopause pill. Find out what MHRA’s decision means for women’s health today.
July 9, 2025
Stablepharma begins world’s first fridge-free vaccine trials; Is the cold chain era ending?
Stablepharma launches the first-ever fridge-free vaccine trial for tetanus and diphtheria—SPVX02—potentially reshaping global vaccine distribution forever.
May 14, 2025
Piramal Pharma expands into paediatric critical care with UK approval for Neoatricon
Piramal Pharma’s Neoatricon secures UK approval, revolutionizing paediatric critical care. Learn how this breakthrough will reshape neonatal hypotension treatment.
March 20, 2025
Vertex Pharmaceuticals bags UK approval for ALYFTREK, a next-generation cystic fibrosis treatment
The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for ALYFTREK (deutivacaftor/tezacaftor/vanzacaftor), a next-generation…
March 7, 2025
MeiraGTx’s rAAV8.hRKp.AIPL1 shows remarkable efficacy in treating severe retinal dystrophy
A gene therapy developed by MeiraGTx Holdings plc has demonstrated remarkable success in restoring vision to children born…
February 24, 2025
MeiraGTx’s gene therapy trial shows transformative results for children with LCA4 retinal dystrophy
MeiraGTx Holdings plc has announced groundbreaking results from its gene therapy trial targeting Leber congenital amaurosis 4 (LCA4),…
February 23, 2025
Dr. Reddy’s Laboratories secures key European endorsement for Rituximab biosimilar
In a significant development for the pharmaceutical industry, Dr. Reddy’s Laboratories Ltd. has received a positive opinion from…
July 30, 2024
UK MHRA approves first generic raltegravir medicines for HIV treatment
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for the first generic raltegravir medicines,…
July 21, 2024
Mundipharma’s rezafungin cleared by MHRA for invasive candidiasis in Great Britain
In a significant advancement for antifungal therapy, Napp Pharmaceuticals Limited, a key player within the international network of…
February 3, 2024